Drug recall D-0037-2026
Product
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.
Reason for recall
Failed Tablet/Capsule Specifications
Lots and codes
Batch # BPB124341A, Exp date: 10/2026
Recall details
- Recalling firm
- Graviti Pharmaceuticals Private Limited, Hyderabad
- Quantity
- 46,512/30 count bottles
- Distribution
- Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 15, 2025
Related products
- Bupropion hydrochloride – drug information
- NDC 16571-863 Bupropion hydrochloride · Bupropion Hydrochloride 300 mg/1 · Rising Pharma Holdings, Inc.
- NDC 16571-862 Bupropion hydrochloride · Bupropion Hydrochloride 150 mg/1 · Rising Pharma Holdings, Inc.